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Vertebrate hematopoietic stem cells (HSCs) emerge
in the aorta-gonad-mesonephros (AGM) region
from ‘‘hemogenic’’ endothelium. Here we show that
the proinflammatory cytokine interferon-g (IFN-g)
and its receptor Crfb17 positively regulate HSC
development in zebrafish. This regulation does not
appear to modulate the proliferation or survival of
HSCs or endothelial cells, but rather the endothe-
lial-to-HSC transition. Notch signaling and blood
flow positively regulate the expression of ifng and
crfb17 in the AGM. Notably, IFN-g overexpression
partially rescues the HSC loss observed in the
absence of blood flow or Notch signaling. Impor-
tantly, IFN-g signaling acts cell autonomously to
control the endothelial-to-HSC transition. IFN-g
activates Stat3, an atypical transducer of IFN-g
signaling, in the AGM, and Stat3 inhibition decreases
HSC formation. Together, our findings uncover a
developmental role for an inflammatory cytokine
and place its action downstream of Notch signaling
and blood flow to control Stat3 activation and HSC
emergence.
INTRODUCTION
Hematopoietic stem cells (HSCs) are multipotent cells with the
self-renewal potential to replenish all blood cell types throughout
life. Their embryonic endothelial cell (EC) origin was proposed
decades ago (Murray, 1932; Sabin, 2002); however, in amniotes,
the process of embryonic endothelial-to-HSC conversion has
only recently been revealed by live imaging of the mouse aorta
(Boisset et al., 2010). Importantly, the detailed progression of
this specific cell transition, in which ECs in the ventral wall of
the dorsal aorta initiate the hematopoietic program and enter cir-
culation, has also been documented in zebrafish (Bertrand et al.,
2010; Kissa and Herbomel, 2010; Lam et al., 2010). These
findings not only confirmed the anatomical and functional equiv-
alence of the zebrafish and mammalian aorta-gonad-meso-
nephros (AGM) region (Taoudi and Medvinsky, 2007), but also
suggested that similar molecular pathways might be operating
among different vertebrates to regulate this endothelial-to-HSC
conversion (Clements and Traver, 2013).
A large number of studies in HSC biology have focused on the
identification and study of transcription factors, cytokines, and640 Developmental Cell 31, 640–653, December 8, 2014 ª2014 Elsevother signaling molecules that are capable of promoting HSC
survival, proliferation, or self-renewal (Sorrentino, 2004; Walasek
et al., 2012). Themajor proinflammatory cytokine IFN-g has been
widely viewed as a negative regulator of HSC self-renewal. This
notion might not be entirely unexpected, particularly under
certain stress conditions such as chronic infection, when robust
cell proliferation and differentiation to restore blood and other
immune cell types could drive dormant HSCs to exhaustion
(Cheng et al., 2000; Sato et al., 2009).More intriguingly, both pro-
liferative and antiproliferative effects of IFN-g on HSCs have
been reported (Yang et al., 2005; Baldridge et al., 2010; King
et al., 2011; de Bruin et al., 2013). These seemingly opposite find-
ings on the relationship between this inflammatory cytokine and
HSC responses led us to speculate that its mode of action might
be broader than anticipated and that environmental cues might
influence its biological effects. Importantly, involvement of IFN-
g in developmental hematopoiesis has not yet been investigated.
Here, we show that IFN-g signaling plays an unexpected role
in HSC development. Embryonic endothelial-to-HSC conversion
is positively regulated by IFN-g signaling, albeit HSCs do not
appear to need IFN-g signaling for their survival or proliferation
in their site of origin. We show that Notch signaling and blood
flow implement at least part of their effect on HSC emergence
by controlling the expression of IFN-g signaling components in
the AGM region. Induction of IFN-g signaling in ECs is able to
confer HSC fate in a cell-autonomous manner. Furthermore,
we show that IFN-g signaling activates Stat3, which is required
for HSC formation. Altogether, our work reveals a previously
unappreciated role for an inflammatory cytokine in HSC
development.RESULTS
Ifng1-2 Induction of HSC Generation
Initially, in order to investigate the role of IFN-g in macrophage
development, we generated a transgenic line expressing a ze-
brafish IFN-g homolog, Ifng1-2, tagged with a V5 epitope under
control of the heat-inducible hsp70l promoter. We included a
cryaa-promoter-driven Cerulean expression cassette in the
construct (Figure 1A) to facilitate identification of the transgenic
embryos by virtue of their fluorescent blue lens. V5 tagging
does not significantly affect the biological activity of Ifng1-2,
as shown by the ability of Ifng1-2-V5 to induce IFN-g target
gene expression (Figure S1A available online). After heat shock,
strong expression of the V5 epitope was detected in numerous
cells all over the trunk of Tg(hsp70l:ifng1-2-V5), abbreviated
Tg(hsp:ifng1-2), embryos (Figure 1C). No Ifng1-2-V5 immuno-
staining was detected after heat shocking embryos that do notier Inc.
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Figure 1. Ifng1-2 and Its Receptor Crfb17 Positively Regulate HSC Development
(A) Schematic drawing of construct for heat-shock-inducible expression of ifng1-2. The area imaged and analyzed in all experiments (red box) is shown in the
embryo illustration.
(B and C) Immunofluorescent labeling of V5-tagged Ifng1-2 (blue) in the vicinity of the AGM of control animals lacking the hsp:ifng1-2-V5 transgene (B) compared
with Tg(hsp:ifng1-2) animals (C). The AGM region is recognized by Tg(kdrl:HRAS-mCherry) expression (red) in the vasculature.
(legend continued on next page)
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positive cells were also found in the vicinity of the AGM, where
the definitive HSCs emerge, as marked by the fluorescent axial
vasculature in the kinase insert domain receptor (also known
as Vegfr2) like (kdrl) reporter line Tg(kdrl:Hsa.HRAS-mCherry),
abbreviated Tg(kdrl:HRAS-mCherry) fish (Chi et al., 2008).
Surprisingly, overexpression of ifng1-2-V5 caused an increase
in the number of cells expressing Tg(6.0itga2b:EGFP) (abbrevi-
ated Tg(itga2b:EGFP); Traver et al., 2003). While itga2b (also
known as cd41) expression is one of the earliest markers of
HSC commitment (Mikkola et al., 2003; Bertrand et al., 2008),
it is also expressed in pronephric cells (in zebrafish) and throm-
bocytes (in mouse and zebrafish) (Bertrand et al., 2008; Zhang
et al., 2007). To further examine the possible involvement of
Ifng1-2 in HSCs development, we crossed the Tg(hsp:ifng1-2)
line to Tg(itga2b:EGFP);Tg(kdrl:HRAS-mCherry) animals in which
HSCs can be distinguished from other Itga2b+ cell types by vir-
tue of their coexpression of cytoplasmic enhanced green fluo-
rescent protein (EGFP) and plasma membrane HRAS-mCherry,
owing to their endothelial origin. When comparing HSCs that
had emerged from the aortic floor or migrated ventrally into the
subaortic space or cardinal vein during definitive hematopoiesis
in control embryos (11.8 ± 1.1 cells per 500 mm aortic length),
we found that Ifng1-2-V5 overexpression resulted in an approx-
imately 31% increase in HSC number (15.4 ± 1.2 cells per
500 mm aortic length) (Figures 1D–1F).
Ifng1-2 and Its Receptor Crfb17 Positively Regulate HSC
Development
Studies in mammalian models have provided essential molecu-
lar details of IFN-g signaling. A functional unit of IFN-g receptor
(IFNGR) is a tetramer consisting of two IFNGR1 and two IFNGR2
chains. IFN-g ligands bind as dimers with high affinity to IFNGR1
to initiate signal transduction (Pestka et al., 2004). In zebrafish,
the transmembrane receptor Crfb17 possesses the conserved
JAK1 and STAT1 binding motifs found in IFNGR1 and is respon-
sible for Ifng1-2 signal transduction (Aggad et al., 2010). To test
the requirement of Ifng1-2 signaling for HSC development,
we generated a crfb17 mutant using transcription activator-like
effector nucleases (Bedell et al., 2012) (Figures S1B and S1C).
In comparison to control (crfb17+/+) siblings, in which HSCs
were readily observed at the ventral wall of the dorsal aorta(D and E) Increased number of HSCs at the ventral wall of the dorsal aorta and in th
control (D) and Tg(hsp:ifng1-2-V5) (E) embryos were fluorescently labeled by Tg(
(F) Number of HSCs per 500 mm aortic length. Values represent means ± SEM, n
and imaged at 52–54 hpf. Of note, the numbers of Tg(itga2b:EGFP)+;Tg(kdrl:HRA
overexpression.
(G–I) Impaired HSC development in crfb17/ embryos. Control (crfb17+/+) (G) and
mCherry+ HSC (white arrowheads) numbers were analyzed prior to genotyping.
embryos, **p% 0.01.
(J–L) Ifng1-2 knockdown recapitulates the HSC phenotype of crfb17 mutants. itg
red in nuclease-free distilled water)-injected (J) or ifng1-2MO-injected (K) embryo
(L). Values represent means ± SEM, n = 32–40 embryos, ***p% 0.001.
(M–O) Reduction of runx1 expression upon Ifng1-2 knockdown is restored by ifn
ifng1-2 MO-injected embryos without (N) and with (O) the hsp70:ifng1-2-V5 trans
(P and Q) ifng1-2 overexpresssion is unable to rescue Crfb17 knockdown. run
hsp70:ifng1-2-V5 transgene. All embryos were heat shocked at 24 hpf, and runx
embryos showing the representative phenotype per total number of embryos ana
(DA); blue brackets identify the cardinal vein (CV). All images are lateral views, d
642 Developmental Cell 31, 640–653, December 8, 2014 ª2014 Elsev(13.3 ± 1.0 cells per 500 mm aortic length), the aortic floor of
crfb17/ embryos harbored substantially fewer HSCs (7.5 ±
1.1 cells per 500 mm aortic length) (Figures 1G–1I).
In agreement with this hematopoietic deficiency in crfb17/
embryos, morpholino (MO)-mediated Ifng1-2 knockdown re-
sulted in a decrease in the number of HSCs found within the
AGM region (3.9 ± 0.4 cells per 500 mm aortic length) when
compared with mock-injected control siblings (10.2 ± 0.7 cells
per 500 mmaortic length) (Figures 1J–1L). Furthermore, we found
that the dorsal aorta expression of the HSC marker runx1 was
diminished in ifng1-2morphants (Figures 1M and 1N). The spec-
ificity of the ifng1-2 MO was addressed by testing the ability of
ifng1-2-V5 overexpression to rescue runx1 expression in these
morphants (Figure 1O).
MO-mediated knockdown of Crfb17 similarly reduced runx1
expression (Figures 1N and 1P). Importantly, this effect could
not be rescued by ifng1-2-V5 overexpression (Figure 1Q), indi-
cating that Crfb17 is required to mediate Ifng1-2 signaling during
HSC development.
IFN-g Signaling Does Not Appear to Modulate the
Proliferation or Survival of HSCs or ECs in the AGM
Region
The alteration of HSC number observed on IFN-g signaling mod-
ulation could be the result of changes in cell proliferation and/or
cell death. To test these possibilities, we first analyzed the cell-
cycling activity of HSCs in the AGM region after ifng1-2-V5 over-
expression. Proliferating cell nuclear antigen (PCNA) (produced
during G1, abundant in S, and declining in G2/M phase) immuno-
fluorescence showed no significant changes in the percentage
of itga2b:EGFP+kdrl:HRAS-mCherry+ cells that exited the quies-
cent state of the cell cycle in Tg(ifng1-2-V5) (53.66%± 4.03%) as
compared with control (55.35% ± 6.12%) animals (Figures 2A–
2C). Live imaging of zebrafish embryos (Bertrand et al., 2010;
Kissa and Herbomel, 2010) has previously revealed that the
generation of HSCs from specialized aortic ECs occurs via trans-
differentiation. Nevertheless, to test a potential effect of IFN-g
signaling on EC division, we assessed the EC cell-cycling rate
on ifng1-2-V5 overexpression. Interestingly, we detected fewer
PCNA+Kdrl+ cells in Tg(hsp:ifng1-2) embryos (21.44 ± 1.67 cells
per 500 mm aortic length) as compared with controls (26.54 ±
1.50 cells per 500 mm aortic length) (Figures S2A–S2C).e cardinal vein lumen upon ifng1-2 overexpression. HSCs (white arrowheads) in
itga2b:EGFP) (green) and Tg(kdrl:HRAS-mCherry) (red) expression.
= 21–22 embryos. *p% 0.05. All embryos were heat-shocked at 24 and 48 hpf
S-mCherry) (only green) pronephric duct cells appear unaffected by Ifng1-2
crfb17/ (H) siblings were imaged at 52–54 hpf, and itga2b:EGFP+kdrl:HRAS-
(I) HSCs per 500 mm aortic length. Values represent means ± SEM, n = 8–14
a2b:EGFP+kdrl:HRAS-mCherry+ HSC (white arrowheads) in mock (1% phenol
s imaged at 52–54 hpf. Numbers of HSCs per 500 mm aortic length is shown in
g1-2 induction. Expression of the HSC marker runx1 in mock-injected (M) and
gene.
x1 expression in crfb17 MO-injected embryos without (P) and with (Q) the
1 expression was assessed by in situ hybridization at 36 hpf. The number of
lyzed is indicated in the lower left corner. Red brackets identify the dorsal aorta
orsal up, anterior to the left.
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caused by elevated levels of Ifng1-2-V5 does not appear to be
caused by a change in HSC or EC proliferation in this region.
We next tested whether the reduction in HSCs caused by
Ifng1-2 or Crfb17 knockdown could be attributed to increased
cell death. To visualize apoptotic cells in live embryos, we
used a transgenic line expressing YFP tagged with the phospha-
tidylserine-binding protein Annexin V (secA5-YFP) under the
control of a ubiquitous TATA-box binding protein (TBP) promoter
(van Ham et al., 2010). Using this tool, we found that the numbers
of apoptotic cells within the axial vessels along the AGM region
were comparable in ifng1-2 morphants (8.3 ± 0.6 cells per
500 mm aortic length), crfb17 morphants (6.0 ± 1.1 cells per
500 mm aortic length), and control mock-injected siblings (6.6 ±
0.7 and 7.7 ± 0.7 cells per 500 mm aortic length, respectively)
(Figures 2D–2I). Similarly, terminal deoxynucleotidyl transferase
(TUNEL)-mediated labeling showed that Ifng1-2 or Crfb17
knockdown did not significantly alter EC apoptosis (6.5 ± 1.0
and 7.3 ± 1.5 cells per 500 mm aortic length, respectively)
compared with control animals (5.6 ± 1.1 cells per 500 mm aortic
length) (Figures 2J–2M). Similarly, we did not observe any signif-
icant difference in the apoptotic rate of HSCs (Kdrl+Itga2b+) on
Ifng1-2 knockdown (Figures S2D–S2F). Together, these results
indicate that increased cell death is not a cause of HSC decrease
following the disruption of Ifng1-2/Crfb17 signaling.
IFN-g Positively Regulates HSC Emergence
Since we did not find evidence for the involvement of Ifng1-2
signaling in the proliferation or survival of HSCs or ECs in the
AGM region, we directed our attention for the cellular mecha-
nisms underlying the change in HSC number to the process of
EC to HSC transition. We performed time-lapse imaging of
Tg(hsp:ifng1-2) embryos and control siblings to follow HSC
emergence from the dorsal aorta. Starting from 8 hr after
heat induction of ifng1-2-V5 expression, the emergence of
HSCs, evident by the initiation of itga2b:EGFP expression in
kdrl:HRAS-mCherry+ ECs at the aortic floor, was more frequent
in Tg(hsp70l:ifng1-2-V5) embryos over the entire 14.6 hr obser-
vation time (Movies S1 and S2; Figures 3A–3F).
Since Runx1 is a critical regulator of the endothelial to HSC
transition (Chen et al., 2009), we checked whether runx1 expres-
sion during the earliest establishment of HSC fate (i.e., just after
the onset of blood circulation) was affected by Ifng1-2 signaling.
MO-mediated knockdown of Ifng1-2 resulted in a reduction of
runx1 expression in 26 hpf (hours postfertilization) embryos (Fig-
ures 3G and 3H). Consequently, the development of hematopoi-
etic progenitor cells, including myeloid lineage cells, marked by
mpx1 expression, in the caudal hematopoietic tissue at 48 hpf
(Figures 3I and 3J) and lymphoid lineage cells, marked by rag1Figure 2. Cell Proliferation and Survival in the Axial Vessels Do Not Ap
(A–C) ifng1-2 overexpression increases HSC number without affecting cell divi
phase, labeled by PCNA immunostaining (blue), in control embryos not harboring
indicated by white circles. PCNA HSCs are marked with white arrowheads. (C) P
means ± SEM, n = 9 embryos per group, n.s., not significant (p > 0.05).
(D–M) Ifng1-2 and Crfb17 knockdown has no effect on apoptosis. Apoptotic c
expression (D–I) and TUNEL assay (J–M) in the axial vessels of MOCK-injected (
embryos at 52–54 hpf. Numbers of Tbp:GAL4;UAS:secA5-YFP+ cells (F and I) a
shown as means ± SEM, n = 11–25 embryos, n.s. p > 0.05. All images are latera
644 Developmental Cell 31, 640–653, December 8, 2014 ª2014 Elsevexpression, in the developing thymus at 4 dpf (days post fertiliza-
tion) (Figure 3K and 3L) was severely compromised in ifng1-2
morphants. Conversely, heat induction of ifng1-2 expression
was able to elevate runx1 transcripts within the AGM region
when heat shock was performed at 20–22 hpf, but not at 10–
12 hpf (Figures 3M–3P and S3). Together, our findings suggest
that Ifng1-2 signaling functions as a positive regulator of HSC
specification.
IFN-g Signaling Acts Downstream of Notch Signaling in
HSC Development
Notch signaling is known to play crucial roles during the estab-
lishment of HSC fate. Mice and zebrafish lacking components
of Notch signaling, including Notch1, Jagged1, Rbpj, and Mind
bomb (a ubiquitin ligase essential for activation of Notch
signaling) fail to execute definitive hematopoiesis at the AGM
region (Kumano et al., 2003; Burns et al., 2005; Robert-Moreno
et al., 2005, 2008). Notch was proposed to act upstream of
Runx1 to specify HSCs since Runx1 induction in a Notch
signaling-deficient background can rescue the loss of HSCs
(Burns et al., 2005; Nakagawa et al., 2006). These studies and
the developmental hematopoiesis role of Ifng1-2 signaling
uncovered here prompted us to investigate the connection
between Notch and Ifng1-2 signaling in HSC specification.
To investigate possible interaction between Ifng1-2 and Notch
signaling, we first tested whether blockage of Notch signaling
would exacerbate the HSC defect caused by Crfb17 deficiency.
WT embryos treated with N-[N-(3,5-difluorophenacetyl)-l-
alanyl]-S-phenylglycine t-butyl ester (DAPT), which blocks Notch
intracellular domain (NICD) release from the plasma membrane,
developed fewer HSCs (8.05 ± 0.49 cells per 500 mm aortic
length) than DMSO-treated siblings (12.63 ± 0.77 cells per
500 mm aortic length) (Figures 4A, 4B, and 4E), in agreement
with previous observations (Kim et al., 2013). In contrast, HSC
numbers in crfb17/ embryos treated with DAPT (7.16 ± 0.62
per 500 mm aortic length) were not significantly different from
those treated with DMSO (7.01 ± 0.34 cells per 500 mm aortic
length) (Figures 4C–4E), indicating that Notch and Ifng1-2 func-
tion in the same pathway. Furthermore, the potency of NICD
overexpression in Tg(1.5hsp70l:Gal4; 5xUAS-E1b:6xMYC-
notch1a), abbreviated Tg(hsp:GAL4; UAS:NICD), to induce
HSCs in mock-injected control embryos (from 9.86 ± 0.96 to
16.03 ± 2.27 cells per 500 mm aortic length) was markedly
reduced when Ifng1-2 was knocked down (4.87 ± 1.33 cells
per 500 mm aortic length) (Figures 4F–4I). More importantly, we
found that the HSC defect caused by DAPT-mediated Notch in-
hibition could be rescued by ifng1-2-V5 overexpression. HSC
numbers in embryos with reduced Notch but enhanced Ifng1-2
signaling (12.41 ± 0.89 cells per 500 mm aortic length) werepear to Be Affected by Gain or Loss of Function of Ifng1-2 Signaling
sion. HSCs (itga2b:EGFP+kdrl:HRAS-mCherry+, green+red+) that exit the G0
the Tg(hsp:ifng1-2-V5) transgene (A), and Tg(hsp:ifng1-2-V5) embryos (B) are
ercentage of PCNA+HSCs per total HSCs in the dorsal aorta. Values represent
ells (green, white arrowheads) visualized by Tg(Tbp:GAL4;UAS:secA5-YFP)
D, G, and J), crfb17 MO-injected (E and L), and Ifng1-2 MO-injected (H and K)
nd TUNEL+kdrl:HRAS-mCherry+ cells per 500 mm dorsal aorta length (M) are
l views, dorsal up and anterior to the left.
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Figure 3. Ifng1-2 Signaling Positively Regulates HSC Emergence
(A–F) Higher frequency of ECs at the aortic floor that turn on HSC marker expression upon ifng1-2 overexpression. Still images captured at different time points
during time-lapse imaging of control (lacking the hsp:ifng1-2-V5 transgene) (A–C) and tg(hsp:ifng1-2-V5) (D–F) embryos starting at 33 hpf, 8 hr after heat shock
(see also Movies S1 and S2). White arrowheads point to HSCs, labeled by Tg(itga2b:EGFP) (green) and Tg(kdrl:HRAS-mCherry) (red) expression, just arisen from
the aortic wall at each indicated time point.
(G–L) Ifng1-2 knockdown reduces the emergence of HSCs and consequently the development of myeloid and lymphoid cells. runx1 expression was assessed
during initiation of definitive HSC development at 26 hpf in mock-injected (G) and ifng1-2MO-injected (H) embryos. Myeloid markermpx1 expression in 48 hpf
mock-injected (I) and ifng1-2MO-injected (J) embryos. Lymphoidmarker rag1 expression in the developing thymus (black circle) of mock-injected (K) and ifng1-2
MO-injected (L) 4 dpf larvae.
(legend continued on next page)
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per 500 mm aortic length) (Figures 4J–4M). Correspondingly,
ifng1-2-V5 overexpression restored the loss of HSCs caused
by MO-mediated knockdown of mind bomb (mib) (Figures
S4A–S4D).
Many genes with pivotal roles in diverse developmental pro-
cesses have been identified as Notch transcriptional targets (Ha-
midi et al., 2011). Thus, we examined whether Notch signaling
could also modulate ifng1-2 or crfb17 expression. Inhibition of
Notch signaling with 12 h-DAPT treatment resulted in a reduction
of ifng1-2 and crfb17 transcripts, typically present in the axial
vessels of DMSO-treated control embryos (Figures 4N–4Q and
S4E). Expression of other homologs of IFN-g and IFNGR1,
ifng1-1, and crfb13, respectively (Aggad et al., 2010), appeared
unaffected by Notch inhibition (Figure S4F). Recent findings indi-
cate that Notch signaling functions downstream of retinoic acid
signaling to mediate hemogenic EC specification through cell-
cycle control. Retinoic acid-deficient mice show a reduction in
the proportion of ECs in the G0 phase and a concomitant in-
crease in the S/G2/M fraction (Marcelo et al., 2013). Therefore,
we tested whether IFN-g signaling-deficient animals also
exhibited this phenotype. Indeed, MO-mediated Ifng1-2 or
Crfb17 knockdown resulted in an increase in the number of
Pcna+ ECs (Figures S4G–S4J), suggesting that Ifng signaling
might be required to restrain ECs in a quiescent state. Collec-
tively, these findings suggest a signaling network in which
Ifng1-2 signaling acts downstream of Notch signaling during
HSC specification.
Blood Flow Regulation of HSC Development Is Mediated
in Part by IFN-g Signaling
Another key regulator of HSC development is blood flow (North
et al., 2009). To investigate the relationship between blood flow
and Ifng1-2 signaling, we checked whether Ifng1-2 induction
could rescue HSC loss in the absence of blood flow. Embryos
injected with tnnt2 (previously known as silent heart) MO (Seh-
nert et al., 2002) lack a heartbeat and consequently show
disturbed vascular development and a reduction of HSCs in
the AGM (2.80 ± 0.61 cells per 500 mm aortic length) as
compared with mock-injected controls (10.02 ± 0.84 cells per
500 mm aortic length). Overexpression of ifng1-2-V5 partially
restored HSCs in tnnt2 morphants (5.67 ± 0.38 cells per
500 mm aortic length) (Figures 5A–5D). Correspondingly, the
decrease of runx1 expression in tnnt2 morphants could be
rescued by ifng-1-2-V5 overexpression (Figures 5E–5G). The
moderate efficiency of ifng1-2-V5 overexpression to restore
HSCs in the absence of circulation led us to test whether flow
affects the expression of IFN-g signaling components in he-
matopoietic tissues. Indeed, we found that the expression
of both ifng1-2 and crfb17 was nearly absent from the axial
vessels of tnnt2 morphants (Figures 5H–5K). This reduction in
ifng1-2 and crfb17 mRNA expression in flow-deficient embryos
was further confirmed by quantitative PCR (qPCR) (Figure 5L).(M–P) Elevated expression of runx1 upon ifng1-2 overexpression. runx1 expressio
and Tg(hsp:ifng1-2) embryos heat-shocked at 10–12 hpf (N) or 20–22 hpf (P). The
embryos analyzed is indicated in the lower left corner. Red brackets identify the do
lateral views, dorsal up and anterior to the left.
646 Developmental Cell 31, 640–653, December 8, 2014 ª2014 ElsevThe role of IFN-g/Crfb17 in HSC formation and the requirement
of blood flow for their expression in the AGM suggest that IFN-g
signaling is a part of the blood flow-regulated mechanism
underlying HSC development.
Cell-Autonomous Action of IFN-g Signaling in HSC
Emergence
Notch was reported to function cell autonomously in HSC spec-
ification (Hadland et al., 2004). Our finding that IFN-g might act
downstream of Notch signaling during this process prompted
us to check whether ECs must experience IFN-g signaling
to become HSCs. Therefore, we generated a nls-Cerulean:
14xUAS:crfb17 construct (Figure 6A) utilizing a bidirectional
14xUAS promoter to drive the expression of crfb17 and nu-
clear-localized Cerulean in a cell-type-specific manner. We in-
jected the nls-Cerulean:14xUAS:crfb17 construct or a control
construct nls-Cerulean:14xUAS into Tg(cdh5:GAL4FF) embryos
to induce crfb17 expression in ECs. We observed higher per-
centages of Crfb17 overexpressing cells activating the HSC
marker itga2b:EGFP (86.70 ± 4.62) when compared with Ceru-
lean overexpression alone (55.10 ± 8.12) (Figures 6B–6D), sug-
gesting that Crfb17 functions cell autonomously in the aortic
endothelium.
To further test this model, we carried out cell transplantations
and found that crfb17/ cells integrated into the dorsal aorta
of WT (crfb17+/+) animals but showed reduced contribution to
the host definitive HSCs (1.23 ± 0.28 crfb17/ as compared
with 2.29 ± 0.42 crfb17+/+ HSCs per 100 mm) (Figures 6E–6H).
Together these data indicate that signaling through Crfb17
acts cell autonomously in dorsal aorta ECs during their differen-
tiation to HSCs.
Stat3 Activated by IFN-g Signaling Positively Regulates
HSC Development
Most biological responses of IFN-g signaling are thought to be
mediated through STAT1 (Platanias, 2005). However, in certain
settings, activation of STAT3 by IFN-g has been reported
(Caldenhoven et al., 1999; Qing and Stark, 2004). Interestingly,
targeted deletion of STAT3 in hematopoietic tissues causes a
reduction in the number of long-term (LT) HSCs in the bone
marrow (Mantel et al., 2012). However, mutation of the STAT1/
3 binding site in Gp130, a receptor that mediates interleukin-6
(IL-6) signal transduction, does not affect HSC repopulation
and self-renewal (Wang et al., 2012). Therefore, the ligand/re-
ceptor pair that activates STAT3 in HSC development remains
unidentified.
To examine the possible involvement of Stat3 in the Ifng1-2/
Crfb17-regulation of HSCs, we first checked whether Ifng1-2 in-
duction could activate Stat3. Elevated levels of tyrosine-phos-
phorylated (i.e., activated) Stat3 were observed in the AGM
following ifng1-2-V5 overexpression (Figures 7A–7D). Moreover,
induction of Notch signaling by NICD overexpression similarly
increased activated Stat3, whereas Notch inhibition by DAPTn in 36-38 hpfWT embryos heat-shocked (h.s.) at 10–12 hpf (M) or 20–22 hpf (O)
number of embryos showing the representative phenotype per total number of
rsal aorta (DA), and blue brackets identify the cardinal vein (CV). All images are
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Figure 4. Ifng1-2 Functions Downstream of Notch Signaling during HSC Development
(A–E) Notch inhibition has no additional effect on HSC impairment in crfb17mutants. HSCs are identified by Tg(itga2b:EGFP) (green) and Tg(kdrl:HRAS-mCherry)
(red) expression (white arrowheads) in DMSO-treated (A) or DAPT-treated (B) WT and DMSO-treated (C) or DAPT-treated (D) crfb17/ embryos. Siblings were
imaged at 52–54 hpf, and HSC numbers were analyzed prior to genotyping. (E) itga2b:EGFP+kdrl:HRAS-mCherry+ cells per 500 mm aortic length. Values
represent means ± SEM, n = 12–13 embryos.
(legend continued on next page)
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were altered correspondingly (Figures 7C and 7E).
We next treated embryos with the Stat3 inhibitor S3I-201,
which blocks Stat3 phosphorylation by targeting its Src homol-
ogy (SH2) domain and found a decrease in the number of
HSCs emerging from the AGM. Moreover, overexpression of
ifng1-2-V5 was unable to rescue this defect (Figures 7F–7I).
Taken together, these findings suggest that Stat3 acts as a
mediator of IFN-g signaling to control HSC formation. A similar
mechanism could be present in mammals, thereby explaining
the reduction of LT HSCs in STAT3 mutants.
DISCUSSION
IFN-g in HSC Development
We report here a role for the potent inflammatory cytokine IFN-g
as a positive regulator of developmental hematopoiesis. During
the early emergence of definitive HSCs at the dorsal aorta, IFN-
g signals through theCrfb17 receptor to stimulate the emergence
of HSCs. Furthermore, we find that Notch signaling and blood
flow, known regulators of HSC development, are required for
the expression of ifng1-2 and crfb17 in this hematopoietic tissue.
Extensive studies on the immune and inflammatory functions
of IFN-g have contributed to the general view that it mediates
the differentiation of hematopoietic cells from HSCs that reside
in the bone marrow at the expense of their self-renewal potential
(Yang et al., 2005; Baldridge et al., 2010; MacNamara et al.,
2011; de Bruin et al., 2013). Within the bone marrow, a compos-
ite of several cell types maintains a specialized microenviron-
ment that regulates HSC homeostasis. In addition to the endo-
thelial and mesenchymal stromal cells that are in close contact
with HSCs, sympathetic nerves and osteolineage cells also pro-
vide molecular cues that affect the maintenance, differentiation,
and mobilization of HSCs (Morrison and Scadden, 2014). A clear
example of the niche influence on IFN-g function is the recent
finding that IFN-g secreted from cytotoxic T cells acts on bone
marrow mesenchymal stromal cells to induce IL-6 production,
which then mediates myeloid differentiation from hematopoietic
progenitor cells (Schu¨rch et al., 2014). Therefore, HSCs are
exposed to distinct signals at their site of origin in the AGM in
comparison to their site of maintenance in the bone marrow,
and these signals could affect the outcome of IFN-g signaling.
Moreover, while previous studies have focused on the role of
IFN-g in quiescent adult HSCs, we now provide evidence for a
cell-autonomous action of Crfb17 in hemogenic ECs. Under in-
flammatory stress, IFN-g was reported to activate STAT1 and
stimulate dormant LT HSCs to enter the cell cycle (Baldridge(F–I) Reduced efficiency of Notch signaling to induceHSCs in the absence of Ifng1
of mock-injected control (F) and Tg(hsp:GAL4;UAS:NICD-myc) embryos (G), and i
was visualized by Tg(Tp1:H2B-mCherry) expression (red).White arrowheads point
cells per 500 mM aortic length. Values represent means ± SEM, n = 8–24 embryo
(J–M) ifng1-2 overexpression rescues the reduction of HSCs caused by Notch in
heads) are imaged in control animals treated with DMSO (J) and DAPT (K) and DA
are shown as means ± SEM, n = 22–33 embryos, n.s. p > 0.05, *p% 0.05, **p% 0.
embryos were imaged at 52–54 hpf.
(N–Q) Inhibition of Notch signaling downregulates crfb17 and ifng1-2 expression.
treated with DMSO (N and P) or DAPT (O and Q) starting at 24 hpf. The number o
analyzed is indicated in the lower left corner. Red brackets identify the dorsal aor
views, dorsal up and anterior to the left.
648 Developmental Cell 31, 640–653, December 8, 2014 ª2014 Elsevet al., 2010). Furthermore, the interferon regulatory factor 7, a
transcriptional mediator of Ifng-Stat1 signaling (Farlik et al.,
2012), negatively affects HSC development when its posttran-
scriptional inhibitor, miR-142a-3p, is knocked down (Lu et al.,
2013). Our work, on the other hand, identifies Stat3 as amediator
of IFN-g signaling during the EC to HSC transition. Thus, the dual
roles of IFN-g signaling in HSC specification and differentiation
appear to be cell-type dependent, and these distinct outcomes
likely involve different effector molecules.
Notch and IFN-g Signaling during HSC Specification
We identified in our studies a Notch-Ifng1-2 signaling network in
the regulation of HSC emergence. However, the relationship be-
tweenNotchand IFN-gmightbemorecomplicated than themere
transcriptional control of IFN-g signaling components by Notch
signaling. The involvement of other mechanisms in the reduction
of ifng1-2 and crfb17 expression in the axial vessels following
Notch inhibition reported here cannot be ruled out. One possibil-
ity is that this reduction might be a secondary effect of the loss of
arterial identity, typically observed in Notch loss-of-function ma-
nipulations (Duarte et al., 2004). In support of this hypothesis, we
found that the decrease of ifng1-2 and crfb17 expression
followingDAPT treatmentwasmorenoticeable in thedorsal aorta
as compared with the cardinal vein (Figures 4N–4Q). Therefore,
additional and yet unidentified artery-specific or Notch-depen-
dent proteins might modulate the transcription and/or posttran-
scriptional control of IFN-g signaling components.
The effect of Notch inhibition by DAPT treatment on HSC
numbers observed here seems moderate when compared with
the reported nearly complete loss of runx1 expression inmibmu-
tants (Burns et al., 2005; Gering and Patient, 2005). One of the
possible explanations is the developmental stagewhen the treat-
ment was applied. To avoid gross developmental abnormalities,
including the loss of some posterior somites (Zhang et al., 2007),
we chose to apply 12–24 hr treatments starting at 24 hpf. This
timing also matches the developmental stage when IFN-g
signaling functions in HSC formation sincewe observed elevated
runx1 expression levels after induction of ifng1-2 expression by
heat shock at 20–22 hpf, but not at 10–12 hpf (Figures 3M–3P).
Furthermore, the role for Notch signaling in HSC development
likely extends beyond the EC-HSC transition. It has recently
been reported that activation of Notch signaling in endothelial
progenitor cells, initiated by their interaction with somitic tissues
and before the formation of the dorsal aorta, is required for HSC
formation (Kobayashi et al., 2014). Therefore, IFN-g signaling
most likely implements only part of the broad range of Notch
signaling functions during definitive hematopoiesis.-2. itga2b:EGFP+ cells (green) are observed in the ventral wall of the dorsal aorta
fng1-2MO-injected Tg(hsp:GAL4;UAS:NICD-myc) embryos (H). Elevated NICD
to itga2b:EGFP+Tp1:H2B-mCherry+ cells. (I) itga2b:EGFP+Tp1:H2B-mCherry+
s, *p% 0.05, **p% 0.01, ***p% 0.001.
hibition. itga2b:EGFP+ (green) kdrl:HRAS-mCherry+ (red) HSCs (white arrow-
PT-treated Tg(hsp:ifng1-2) animals (L). HSC numbers per 500 mm aortic length
01, ***p% 0.001. All heat-shock treatments were done at 24 and 48 hpf, and all
crfb17 (N and O) and ifng1-2 (P and Q) expression is shown in 36 hpf embryos
f embryos showing the representative phenotype per total number of embryos
ta (DA), and blue brackets identify the cardinal vein (CV). All images are lateral
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Figure 5. Reduced Ifng1-2 Signaling Is Partially Responsible for the HSC Developmental Defects Caused by the Lack of Blood Flow
(A–D) ifng1-2 overexpression partly restores HSCs in embryos with no circulation. itga2b:EGFP+ (green) kdrl:HRAS-mCherry+ (red) HSCs (white arrowheads) are
shown in mock-injected controls (A) and tnnt2 MO-injected embryos without (B) and with (C) hsp:ifng1-2 transgene. All embryos were heat shocked at 24 and
48 hpf and imaged at 52–54 hpf. (D) HSC numbers per 500 mm aortic length are shown as means ± SEM, n = 12–20 embryos, **p% 0.01, ***p% 0.001.
(E–G) Loss of runx1 expression from the lack of blood flow is rescued by ifng1-2 overexpression. runx1 expression is shown in mock-injected controls (E) and
tnnt2 MO-injected embryos without (F) and with (G) the hsp:ifng1-2 transgene. All embryos were heat-shocked at 24 hpf and harvested at 36 hpf.
(H–K) crfb17 and ifng1-2 expression depends on blood flow. crfb17 (H and I) and ifng1-2 (J and K) expression is shown in mock-injected (H and J) and tnnt2
MO-injected (I and K) 36 hpf embryos. The number of embryos showing the representative phenotype per total number of embryos analyzed is indicated in the
lower left corner. Red brackets identify the dorsal aorta (DA), and blue brackets identify the cardinal vein (CV). All images are lateral views, dorsal up and anterior to
the left. qPCR assay of ifng1-2 and crfb17 expression at 36 hpf in tnnt2 MO-injected embryos compared with mock-injected siblings, n = 3, 30 embryos per
sample, *p% 0.05.
(L) qPCR assay of ifng1-2 and crfb17 expression at 36 hpf in tnnt2MO-injected embryos compared with mock-injected siblings, n = 3, 30 embryos per sample,
*p% 0.05.
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IFNGR1-deficient mice show reducedmitotic activity in the bone
marrow-residing quiescent HSCs following bacterial infection.
Nevertheless, the total number of HSCs, sorted by HoechstDevelopm33342-effluxed (so-called side population [SP]) Kit+Sca+Lin
(SPKSL), was not found to be significantly altered when
compared with WT animals (Baldridge et al., 2010). However,
analysis of the HSC pool with an additional marker, CD150,ental Cell 31, 640–653, December 8, 2014 ª2014 Elsevier Inc. 649
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Figure 6. Crfb17 Signaling Acts Cell Auton-
omously to Regulate HSC Emergence
(A–D) crfb17 overexpression in ECs induces HSC
emergence. (A) Schematic drawing of the bidi-
rectional 14xUAS-driven nls-Cerulean and crfb17
expression construct. Tg(cdh5:GAL4FF) embryos
were injected with the control construct nls-cer-
ulean:14xUAS (B) or the nls-Cerulean:14xUAS:
crfb17 construct (C). nls-Cerulean+ (red) cells that
turned on theHSCmarker itga2b:EGFP+ (green) are
indicated by white asterisks. White arrowheads
point to itga2b:EGFPnls-Cerulean+ cells. (D) Per-
centages of itga2b:EGFP+nls-Cerulean+ per total
nls-Cerulean+ cells are shown as means ± SEM,
n = 13–16 embryos, **p% 0.01.
(E–H) Crfb17 is required cell autonomously in
the HSC lineage. (E) Schematic drawing of the
transplantation assay; 52–54 hpf embryos with
transplanted cells from control (crfb17+/+) (F) or
crfb17/ (G) embryos carrying the Tg(itga2b:
EGFP) (green) and Tg(kdrl:HRAS-mCherry) (red)
transgenes. White arrowheads point to green+
red+ HSCs. (H) Numbers of itga2b:EGFP+kdrl:
HRAS-mCherry+ cells per 100 mm aortic length
are shown as means ± SEM, n = 16–20 embryos,
*p% 0.05.
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(Kiel et al., 2005), revealed a reduction in the proportion of the
CD150+KSL population in these mutant mice (Baldridge et al.,
2010). Moreover, the numbers of KSL CD150+CD48+CD34+-
CD135 cells, which represent a more differentiated progenitor
pool, were also lower in the absence of IFNGR1 (MacNamara
et al., 2011). Accordingly, a significant reduction in the numbers
of KSL CD34 cells, which represent a pool of LT-HSCs, was re-
ported in the bone marrow of mice lacking STAT3 (Mantel et al.,
2012). Together, these reports on the decrease of certain he-
matopoietic stem/progenitor cell pools observed in adult mouse
mutants indicate that the role of Ifng1-2 signaling in HSC emer-
gence, reported here in zebrafish, could represent a mechanism
common to other vertebrate models and that its requirement
cannot be fully compensated for over the course of development.
EXPERIMENTAL PROCEDURES
Fish Care and Strains
Embryos and adult fish were raised under standard conditions following the
institution’s ethical guidelines. Please refer to the supplemental information
for the transgenic lines used in this study.
Generation of Transgenic and Mutant Lines
Expression constructs and transgenic and mutant lines were generated as
described in the supplemental information.
In Situ Hybridization and MOs
Whole-mount in situ hybridization was performed as described previously
(Thisse and Thisse, 2008). Primers used for probe generation are described650 Developmental Cell 31, 640–653, December 8, 2014 ª2014 Elsevier Inc.in the supplemental information. Antisense MOs
for Ifng1-2 (Sieger et al., 2009), Crfb17 (Aggad
et al., 2010), Mib (mib-m2-MO) (Zhang et al.,
2007), and Tnnt2 (Sehnert et al., 2002) knock-
down were purchased from Gene Tools and in-
jected into one- or two-cell stage embryos at aconcentration of 0.12, 0.3, 1.0, and 0.3 mM or approximately 2, 5, 17, and
5 ng, respectively.
Immunofluorescence Staining
Embryos were fixed in 4% paraformaldehyde (PFA) and permeabilized
by incubation with 10 mg/ml proteinase K at room temperature for
30 min. Immunofluorescence staining was carried out as described (Sawami-
phak et al., 2010). Mouse anti-PCNA (Santa Cruz) were used at a dilution
of 1:50.
Immunoblotting
Immunoblotting was performed as described (Sawamiphak et al., 2010).
Mouse anti-PhosphoStat3, rabbit anti-Stat3 (Santa Cruz), and rabbit anti-actin
(Cell Signaling Technology) were used at a dilution of 1:500, 1:500, and
1:1,000, respectively.
Embryo Heat Shock and Chemical Treatments
Embryos were heat shocked once at 24 hpf or twice at 24 and 48 hpf by
incubating the cell-culture plates containing the embryos at 37C for 1 hr.
The plates were then transferred back to a 28C incubator until imaging or har-
vesting time. To inhibit Notch signaling, embryos were treated with 100 mM
DAPT (Sigma) in Danieau solution. Siblings treated with 1% DMSO in Danieau
solution were used as controls.
Time-Lapse Microscopy
Embryoswere embedded in 1.2% low-melting agarose in glass-bottomdishes
(MatTek), with their lateral side fully exposed. The dishes were then filled with
Danieau buffer containing 0.016% Tricaine to anesthetize the embryos. For
confocal time-lapse imaging, z stacks of 4 or 4.5 mm intervals were acquired
from the AGM area every 10 or 15min for 14.5–15 hr using a 203water immer-
sion objective. Individual images were rendered into time-lapse movies with
Fiji software.
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Figure 7. STAT3 Is Activated upon ifng1-2 Induction and Positively Regulates HSC Development
(A and B) ifng1-2 overexpression stimulates Stat3 activation in the AGM region. (A) Immunofluorescent staining of phosphorylated Stat3 (pStat3, green) in
embryos without (A) and with (B) the hsp:ifng1-2 transgene. All embryos were heat shocked at 24 and 48 hpf and harvested at 52–54 hpf. The AGM region is
recognizable by the vascular expression of kdrl:HRAS-mCherry (red).
(C–E) Ifng1-2 and Notch signaling regulate Stat3 activation. (C) Western blot analysis of pStat3, total Stat3, and actin expression in the dissected yolk-spanning
region of the trunk. Dissected area is outlined by dashed lines in the embryo illustration; 36 hpf embryos were heat shocked for 5 and 8 hr for ifng1-2 and NICD
overexpression, respectively. DMSO and DAPT treatments were done from 24–48 hpf. (D) Relative expression of pStat3 normalized to Actin. (E) Relative
expression of total Stat3 normalized to Actin. Values represent means ± SEM, n = 3–4 independent experiments, n.s. p > 0.05, *p% 0.05, **p% 0.01.
(F–I) Stat3 inhibition causes a reduction in HSC numbers that cannot be restored by ifng1-2 overexpression. itga2b:EGFP+ (green) kdrl:HRAS-mCherry+ (red)
HSCs (white arrowheads) in control embryos (not carrying the hsp:ifng1-2-V5 transgene) treated with DMSO (F) or Stat3 inhibitor (inh) (G) and Tg(hsp:ifng1-2-V5)
embryos treated with Stat3 inh (H). All embryos were heat shocked at 24 and 48 hpf and imaged at 52–54 hpf. DMSO and Stat3 inh treatments started at 24 hpf. (I)
Numbers of itga2b:EGFP+kdrl:HRAS-mCherry+ cells per 500 mm aortic length are shown as means ± SEM, n = 19–24 embryos, n.s. p > 0.05, **p% 0.01.
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Quantitative analysis was performed using the Fiji software. All confocal z
stacks were first converted into ‘‘sum slices’’ projections. Aortic lengths
were measured along the ventral wall of the dorsal aorta across the micro-
scopic field, which covered approximately 85% of the yolk extension span.DevelopmHSCs and apoptotic and proliferating cells were counted and normalized to
aortic length or calculated as percentages of total numbers of HSCs or ECs.
Equality of variance between the experimental and control sample sets was
analyzed using the F test. The two-tailed unpaired Student’s t test was used
to calculate significance.ental Cell 31, 640–653, December 8, 2014 ª2014 Elsevier Inc. 651
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Total RNA isolated from 20–30 embryos was reverse transcribed using Super-
script II (Life Technologies), and gene expression was assayed relative to
rps11 and/or glyceraldehyde 3-phosphate dehydrogenase (gapdh) using an
Eco Real-Time PCR System (Illumina). All reactions were performed in tech-
nical triplicates, and the results represent biological replicates, including the
standard error of the mean, unless otherwise stated. Primers are listed in the
Supplemental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2014.11.007.ACKNOWLEDGMENTS
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